NBO Pharma Inc.
New Filing
CIK: 0002103906·Pharmaceuticals·DELAWARE·Filed: Nov 9, 2026
Total Offering
$7,000,000
Amount Sold
$238,000
Investors
5
First Sale
Nov 2, 2026
Offering Details
- Type
- Equity, Option to Acquire
- Exemptions
- Rule 506(c)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Fredric David Price | Related Person |
| Robert Friedman | Related Person |
| Colin Foster | Related Person |
| Bard Geesaman | Related Person |
Company
SEC Filing
0002103906-26-000002
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free